Seasoned life sciences, therapeutic and functional expertise
Rigorous market research, real-world data and proprietary benchmarks
Cutting edge analytics and digital transformation solutions with clinical & commercial applications
Webinars
The NRDL Conundrum: Balancing Between Access and Pricing for Innovation
May 21, 2025 | 1:00 – 1:45 PM ET
What key insights emerged from the 2024 China National Reimbursement Drug List (NRDL) negotiations and how can they inform strategic go-to-market planning for innovative therapies? In the 2024 NRDL negotiations, only 28% of submitted products passed expert review, significantly raising the bar for entering pricing negotiations.
Sign Up Now
Blog
Navigating the CRM Split: Generating Buy‑In
The transition to a new CRM system is more than just a technical migration; it’s a strategic choice that requires careful consideration and a strong point of view on what your organization needs for success. To navigate the CRM transition necessitated by the Salesforce-Veeva split, it’s crucial to generate buy-in from account and field teams […]
Read More
White Papers
Predicting Winners: AI-Powered Portfolio Management
Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry? In this installment of our Industry Impact Series, we find that not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for […]
Read More
